Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Yang‑Jia Zhuo"'
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-1 (2023)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12943-017-0615-x.
Externí odkaz:
https://doaj.org/article/d042f4c5d6534ece87fd5ad57750dda9
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 16, Iss 1, Pp 1-14 (2017)
Abstract Background Even though aberrant expression of microRNA (miR)-30d has been reported in prostate cancer (PCa), its associations with cancer progression remain contradictory. The aim of this study was to investigate clinical significance, biolo
Externí odkaz:
https://doaj.org/article/dafef72eefd84824ae9aabaaf94a8720
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 18, Iss 1, Pp 1-2 (2019)
After publication of the article [1], the author reported that this article contained some errors.
Externí odkaz:
https://doaj.org/article/d0690d58a7594798b70a58449981c3ce
Autor:
Yu-Xiang Liang, Ying-Ke Liang, Zhi-Hao Zou, Yang-Jia Zhuo, Jian-Heng Ye, Xue-Jin Zhu, Zhou-Da Cai, Zhuo-Yuan Lin, Ru-Jun Mo, Shu-Lin Wu, Yan-Qiong Zhang, Wei-De Zhong
Publikováno v:
Disease Markers.
Background. In our previous research, we developed a 32-gene risk index model that may be utilized as a robust prognostic method for predicting prostate cancer (PCa) recurrence after surgery. Among the 32 genes, the Fifth Ewing Variant (FEV) gene was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4acdc73f98cf3040e277463149a011
Autor:
Yu-Xiang, Liang, Ying-Ke, Liang, Zhi-Hao, Zou, Yang-Jia, Zhuo, Jian-Heng, Ye, Xue-Jin, Zhu, Zhou-Da, Cai, Zhuo-Yuan, Lin, Ru-Jun, Mo, Shu-Lin, Wu, Yan-Qiong, Zhang, Wei-De, Zhong
Publikováno v:
Disease markers. 2022
In our previous research, we developed a 32-gene risk index model that may be utilized as a robust prognostic method for predicting prostate cancer (PCa) recurrence after surgery. Among the 32 genes, the Fifth Ewing Variant (FEV mRNA expression was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::455d2a22be44cba7de01f479cd4e01ed
https://pubmed.ncbi.nlm.nih.gov/35548776
https://pubmed.ncbi.nlm.nih.gov/35548776
Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer
Autor:
Chin-Lee Wu, Zhi duan Cai, Yang jia Zhuo, Yue ping Wan, Sheng da Song, Song Wan, Ze zhen Liu, Wei-de Zhong, Jian jiang Xie, Wei Hua, Zhou da Cai
Publikováno v:
Biomedicine & Pharmacotherapy. 102:531-538
Serine/Arginine-Rich Protein-Specific Kinase-2 (SRSF protein kinase-2, SRPK2) is up-regulated in multiple human tumors. However, the expression, function and clinical significance of SRPK2 in prostate cancer (PCa) has not yet been understood. We ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee60ddd7e5800c16fb1c23ee608c273
https://doi.org/10.1016/j.biopha.2018.03.079
https://doi.org/10.1016/j.biopha.2018.03.079
Autor:
Wei-de Zhong, Hao Fu, Jianming Lu, Jia-Hong Chen, Yang‑Jia Zhuo, Zhi‑Yun Chen, Zhenyu Jia, Xiao‑Hui Ling
Publikováno v:
Oncology Reports.
Previous researchers have demonstrated that microRNA‑505 (miR‑505) is negatively correlated with progression in various malignancies. However, the detailed function and molecular mechanisms of miR‑505 have yet to be completely elucidated in pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c782a21ce318386e6d37a402b709005d
https://doi.org/10.3892/or.2019.7231
https://doi.org/10.3892/or.2019.7231
Autor:
Wei-de Zhong, Jia-Hong Chen, Yang‑Jia Zhuo, Hao Fu, Zhenyu Jia, Zhi‑Yun Chen, Xiao‑Hui Ling, Jianming Lu
Publikováno v:
Oncology Reports
Previous researchers have demonstrated that microRNA-505 (miR-505) is negatively correlated with progression in various malignancies. However, the detailed function and molecular mechanisms of miR-505 have yet to be completely elucidated in prostate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5b420f57fa2ae66f01c7edd9c791ea
http://europepmc.org/articles/PMC7469085
http://europepmc.org/articles/PMC7469085
Autor:
Zhuo-Yuan Lin, Chen, Guo, Zhang, Yan-Qiong, Hui-Chan He, Liang, Yu-Xiang, Ye, Jian-Heng, Ying-Ke Liang, Mo, Ru-Jun, Lu, Jian-Ming, Yang-Jia Zhuo, Zheng, Yu, Fu-Neng Jiang, Han, Zhao-Dong, Wu, Shu-Lin, Wei-De Zhong, Chin-Lee Wu
A schematic diagram of the systematic strategies for uncovering the involvement of miR-30d in human prostate cancer (PCa). Figure S2. miR-30d expression in human PCa cell lines (A) and clinical PCa tissues (B). Data were presented as Mean Âą SD. **
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e50851998f0164515a55f46aa37cbd0
Autor:
Zhuo-Yuan Lin, Chen, Guo, Zhang, Yan-Qiong, Hui-Chan He, Liang, Yu-Xiang, Ye, Jian-Heng, Ying-Ke Liang, Mo, Ru-Jun, Lu, Jian-Ming, Yang-Jia Zhuo, Zheng, Yu, Fu-Neng Jiang, Han, Zhao-Dong, Wu, Shu-Lin, Wei-De Zhong, Chin-Lee Wu
The sequences of all the primers. Table S2. The antibodies of all proteins. Table S3. Associations of miR-30d expression with various clinicopathological parameters of PCa patients based on Taylor and TCGA datasets. Table S4. Univariate and multivari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5fa8b9e29be03ba7aadd8b6c79d1113